YCM
ALNY icon

Yousif Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Yousif Capital Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$550K Buy
1,828
+64
+4% +$19.3K 0.01% 1313
2026
Q1 		$584K Buy
1,764
+88
+5% +$29.9K 0.01% 1332
2025
Q4 		$596K Buy
1,676
+29
+2% +$12.8K 0.01% 1334
2025
Q3 		$751K Buy
1,647
+80
+5% +$32.6K 0.01% 1249
2025
Q2 		$511K Sell
1,567
-106
-6% -$29.3K 0.01% 1447
2025
Q1 		$452K Buy
1,673
+31
+2% +$7.97K 0.01% 1479
2024
Q4 		$386K Buy
1,642
+9
+0.6% +$2.37K ﹤0.01% 1582
2024
Q3 		$449K Buy
1,633
+20
+1% +$5.21K ﹤0.01% 1542
2024
Q2 		$392K Sell
1,613
-22
-1% -$3.47K ﹤0.01% 1579
2024
Q1 		$244K Buy
1,635
+144
+10% +$24K ﹤0.01% 1811
2023
Q4 		$285K Buy
1,491
+45
+3% +$7.67K ﹤0.01% 1769
2023
Q3 		$256K Buy
1,446
+40
+3% +$7.63K ﹤0.01% 1764
2023
Q2 		$267K Sell
1,406
-21
-1% -$4.16K ﹤0.01% 1758
2023
Q1 		$286K Buy
1,427
+50
+4% +$10.5K ﹤0.01% 1717
2022
Q4 		$327K Buy
1,377
+245
+22% +$52.3K ﹤0.01% 1677
2022
Q3 		$227K Buy
+1,132
New +$216K ﹤0.01% 1776
2022
Q2 		– Sell
-1,751
Closed -$286K – 1978
2022
Q1 		$286K Buy
1,751
+70
+4% +$10.7K ﹤0.01% 1816
2021
Q4 		$285K Buy
+1,681
New +$312K ﹤0.01% 1840

Other funds holding ALNY

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
SSA
Sierra Summit Advisors Incline Village, Nevada $895M AUM 106% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Yousif Capital Management's ALNY Position: Q2 2026 in Review

Yousif Capital Management increased its Alnylam Pharmaceuticals (ALNY) stake by 3.6% in Q2 2026, buying an estimated $19.3K and bringing the position to 1,828 shares worth $550K. The position accounts for 0.01% of the portfolio, ranked #1313.

Yousif Capital Management first reported a position in ALNY in Q4 2021 and has held it in 18 quarters since. The position peaked at $751K in Q3 2025. 149 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Yousif Capital Management held 1,828 shares of Alnylam Pharmaceuticals worth $550K as of Q2 2026.
  • Yousif Capital Management bought 64 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $19.3K.
  • Alnylam Pharmaceuticals made up 0.01% of Yousif Capital Management's portfolio in Q2 2026, its #1313 holding.
  • Yousif Capital Management first reported a position in Alnylam Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • Yousif Capital Management's Alnylam Pharmaceuticals position peaked at $751K in Q3 2025.
  • 149 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.